Formulation and optimization of sustained release tablets of venlafaxine resinates using response surface methodology

Area of Science:

• Pharmaceutical Technology
• Drug Delivery Systems
• Materials Science

Background:

• Venlafaxine hydrochloride is a widely used antidepressant.
• Developing sustained-release formulations improves patient compliance and therapeutic efficacy.
• Ion exchange resins offer potential for controlled drug release applications.

Purpose of the Study:

• To design and optimize sustained-release matrix tablets of venlafaxine hydrochloride.
• To utilize ion exchange resin (Indion 244) for drug loading.
• To incorporate hydrophilic and hydrophobic polymers for controlled release.

Main Methods:

• Venlafaxine HCl was loaded onto Indion 244 via batch method.
• Resinates were wet granulated with ethylcellulose and blended with hydroxypropylmethylcellulose.
• A central composite design (2 factors, 3 levels) was used for optimization.
• Response surface methodology was employed to analyze drug release profiles.

Main Results:

• Optimized matrices exhibited anomalous release mechanism (release exponent n=0.8109–0.8719).
• Formulations demonstrated regulated and complete drug release up to 20 hours.
• Response surface methodology showed high prognostic ability with low mean percentage error (1.152±1.88%).

Conclusions:

• Hydrophilic and hydrophobic matrix tablets of venlafaxine resinate can be successfully developed.
• The optimized formulation serves as an effective once-a-day oral controlled-release drug delivery system.
• This approach enhances the therapeutic potential of venlafaxine hydrochloride through controlled release.